25 related articles for article (PubMed ID: 11680936)
1. Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells.
Li ZL; Wang ZJ; Wei GH; Yang Y; Wang XW
World J Gastrointest Oncol; 2020 Mar; 12(3):267-275. PubMed ID: 32206177
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).
Chen T; Yang P; Jia Y
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448320
[TBL] [Abstract][Full Text] [Related]
3. Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2.
Danielsen ET; Olsen AK; Coskun M; Nonboe AW; Larsen S; Dahlgaard K; Bennett EP; Mitchelmore C; Vogel LK; Troelsen JT
Sci Rep; 2018 Aug; 8(1):11813. PubMed ID: 30087389
[TBL] [Abstract][Full Text] [Related]
4. Implication of gelatinases in retinoblastoma development.
Zamfir-Chiru-Anton A; Gheorghe Dan C
Rom J Ophthalmol; 2016; 60(2):68-70. PubMed ID: 29450326
[TBL] [Abstract][Full Text] [Related]
5. Resistance of MMP9 and TIMP1 to endotoxin tolerance.
Muthukuru M; Cutler CW
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25951835
[TBL] [Abstract][Full Text] [Related]
6. Determination of oral bioavailability of fusaric acid in male Sprague-Dawley rats.
Stack BC; Ye J; Willis R; Hubbard M; Hendrickson HP
Drugs R D; 2014 Jun; 14(2):139-45. PubMed ID: 24903027
[TBL] [Abstract][Full Text] [Related]
7. The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.
Lu H; Yang Z; Zhang H; Gan M; Zhou T; Wang S
Exp Ther Med; 2013 Mar; 5(3):890-896. PubMed ID: 23408109
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.
Long H; Zhou B; Jiang FG
Int J Ophthalmol; 2011; 4(5):489-91. PubMed ID: 22553708
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
[TBL] [Abstract][Full Text] [Related]
10. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.
Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A
J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743
[TBL] [Abstract][Full Text] [Related]
11. Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.
Guo WJ; Li J; Ling WL; Bai YR; Zhang WZ; Cheng YF; Gu WH; Zhuang JY
World J Gastroenterol; 2002 Jun; 8(3):476-9. PubMed ID: 12046073
[TBL] [Abstract][Full Text] [Related]
12. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
[TBL] [Abstract][Full Text] [Related]
13. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Zeng ZS; Guillem JG
Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
15. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Ogata Y; Miura K; Ohkita A; Nagase H; Shirouzu K
Kurume Med J; 2001; 48(3):211-8. PubMed ID: 11680936
[TBL] [Abstract][Full Text] [Related]
17. [Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer].
Ogata Y; Ookita A; Kakegawa T
Nihon Rinsho; 1995 Jul; 53(7):1811-5. PubMed ID: 7630024
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
